COVID-19 Related Pancreatic Cancer Surveillance Disruptions Amongst High-Risk Individuals
COVID-19 pandemic-related disruptions to EUS-based pancreatic cancer surveillance in high-risk individuals remain uncertain.
Analysis of enrolled participants in the CAPS5 Study, a prospective multicenter study of pancreatic cancer surveillance in high-risk individuals Read more . . .